NBSE
NeuBase Therapeutics Inc

1,602
Loading...
Loading...
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for NeuBase Therapeutics Inc?
What is the 52-week low for NeuBase Therapeutics Inc?
What is NeuBase Therapeutics Inc stock price today?
What was NeuBase Therapeutics Inc stock price yesterday?
What is the 50-day moving average of NeuBase Therapeutics Inc?

Latest NBSE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.